RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 12 analysts with an average price target of $53.49. This is a potential upside of $26.24 (96.29%) from yesterday's end of day stock price of $27.25.

Rocket Pharmaceuticals's activity chart (see below) currently has 31 price targets and 67 ratings on display. The stock rating distribution of RCKT is 97.67% BUY and 2.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.23% with an average time for these price targets to be met of 151.38 days.

Highest price target for RCKT is $61, Lowest price target is $35, average price target is $53.49.

Most recent stock forecast was given by COLIN BRISTOW from UBS on 01-Mar-2024. First documented stock forecast 27-Nov-2018.

Currently out of the existing stock ratings of RCKT, 42 are a BUY (97.67%), 1 are a HOLD (2.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

54

$26.75 (98.17%)

62

27 days ago

0/2 (0%)

$23.47 (76.88%)

Buy

50

$22.75 (83.49%)

9

1 months 1 days ago

2/5 (40%)

$19.26 (62.65%)

88

Buy

53

$25.75 (94.50%)

53

1 months 15 days ago

0/9 (0%)

$24.03 (82.95%)

Buy

50

$22.75 (83.49%)

47

4 months 20 days ago

0/3 (0%)

$30.43 (155.49%)

Buy

48

$20.75 (76.15%)

48

6 months 15 days ago

0/4 (0%)

$26.77 (126.10%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 151.38 days on average for the stock forecasts to be realized with a an average price target met ratio 24.23

Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?

ESTHER RAJAVELU

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu has 8 price targets and 3 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Joshua Schimmer with highest potential upside - $56.4

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?